Susan Louw to Risk Factors
This is a "connection" page, showing publications Susan Louw has written about Risk Factors.
Connection Strength
0,496
-
Safety and efficacy of adjusted-dose enoxaparin in pregnant patients with increased risk for venous thromboembolic disease. Int J Gynaecol Obstet. 2019 Apr; 145(1):70-75.
Score: 0,119
-
The Utility of the Lipoprotein-Associated Phospholipase A2 (Lp-PLA2) Assay in Detecting Abnormalities in Lipid Metabolism and Cardiovascular Risk in an HIV-Infected South African Cohort. Clin Appl Thromb Hemost. 2019 Jan-Dec; 25:1076029619883944.
Score: 0,118
-
Pathogenic factors associated with development of disseminated intravascular coagulopathy (DIC) in a tertiary academic hospital in South Africa. PLoS One. 2018; 13(4):e0195793.
Score: 0,113
-
Human immunodeficiency virus infection and acute deep vein thromboses. Clin Appl Thromb Hemost. 2008 Jul; 14(3):352-5.
Score: 0,054
-
Early Online. S Afr Med J. 2024 Jul 19; 114(7):e2109.
Score: 0,043
-
Conservative Management of Overanticoagulation in Patients With Low-Moderate Risk for Bleeding Complications. Clin Appl Thromb Hemost. 2018 Nov; 24(8):1255-1260.
Score: 0,029
-
Venous thromboembolism: prophylactic and therapeutic practice guideline. S Afr Med J. 2013 Feb 15; 103(4 Pt 2):261-7.
Score: 0,020